Get the Stockscreener App
0.5906
3.10%
-0.0189
After Hours:
.60
0.0094
+1.59%
Nexgel Inc stock is traded at $0.5906, with a volume of 44,772.
It is down -3.10% in the last 24 hours and down -0.08% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.6095
Open:
$0.6075
24h Volume:
44,772
Relative Volume:
0.13
Market Cap:
$5.23M
Revenue:
$11.42M
Net Income/Loss:
$-2.89M
P/E Ratio:
-1.5501
EPS:
-0.381
Net Cash Flow:
$-1.38M
1W Performance:
-2.54%
1M Performance:
-0.08%
6M Performance:
-75.08%
1Y Performance:
-77.37%
1-Day Range:
$0.5903
$0.6075
1-Week Range:
$0.58
$0.64
52-Week Range:
$0.56
$2.968
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.5906 | 5.39M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc Stock (NXGL) Latest News
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal - MyChesCo
NexGel Inc Warrant (NXGLW) - Minichart
NexGel Appoints Ian Blackman as New Chief Financial Officer - The Globe and Mail
NexGel, Inc. 2025 SEC Filing – Executive Compensation, Corporate Governance, Ownership & Audit Disclosure - Minichart
Board pay, ownership and new CFO terms at NexGel (NASDAQ: NXGL) - Stock Titan
NEXGEL (NASDAQ: NXGL) hires new CFO to support Celularity deal - Stock Titan
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical - MyChesCo
Asymmetry Point LP (NXGL) files Schedule 13G/A showing 8.8% ownership - Stock Titan
NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition - MSN
Langhorne’s Nexgel Transforms Near Disaster into ‘Three-Team Trade’ Acquisition - BUCKSCO.Today
NEXGEL Appoints Ian Blackman as Chief Financial Officer - Investing News Network
Nexgel, Inc. Appoints Ian Blackman as Chief Financial Officer - marketscreener.com
Inside the deal: After investor bails, Nexgel scrambles to save acquisition that will triple revenue - The Business Journals
NexGel receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com India
NEXGEL, INC. Receives Nasdaq Delisting Notice for Failure to Meet Minimum Bid Price Requirement - Minichart
NexGel receives Nasdaq notice for minimum bid price deficiency - Investing.com
NexGel Receives Nasdaq Deficiency Notice Over Bid Price - TipRanks
NexGel Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NexGel (NASDAQ: NXGL) warned by Nasdaq over sub-$1 share price and delisting risk - Stock Titan
NXGL (NexGel Inc) shares fall over 15 percent after Q4 2025 EPS loss lands far below analyst consensus estimates.Fast Rising Picks - Xã Thanh Hà
NexGel Bets Big With Transformational Acquisition And Financing - The Globe and Mail
NEXGEL Reschedules Shareholder Call, Revises Celularity Financing - MyChesCo
NEXGEL closes Celularity biomaterials deal, raises $5.5 million By Investing.com - Investing.com India
Celularity Announces Closing of Transaction with NexGel - Investing News Network
NXGL: Acquisition triples revenue and accelerates profitability, transforming the business platform - TradingView
Nexgel Inc co and Celularity enter amendment no. 1 to license agreement on April 17, 2026 - marketscreener.com
Nexgel IncCo to Pay Celularity $13.3 Mln I - Moomoo
NEXGEL Secures Strategic Financing and Regenerative Portfolio License - TipRanks
NexGel Closes Celularity Biomaterials License Terms and Secures $6.9M Convertible Note Financing - TradingView
NEXGEL (NASDAQ: NXGL) triples revenue outlook with Celularity deal, $6.9M notes - Stock Titan
Celularity Inc. announced that it has received $13.3 million in funding from NEXGEL, Inc. - marketscreener.com
NexGel closes acquisition of products from Celularity - TipRanks
Celularity Closes $13.3 Million Asset Sale to NexGel, Strengthening Focus on Longevity Therapeutics and Balance Sheet 1 - Minichart
NEXGEL New Strategic Partner, Sequence LifeScience, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment - Investing News Network
Nexgel new strategic partner, Sequence LifeScience, leads financing with $5.5 million to complete acquisition of Celularity degenerative disease segment - marketscreener.com
Celularity Closes NexGel Asset Sale, Refocuses on Cell Therapy - TipRanks
NEXGEL closes Celularity biomaterials deal, raises $5.5 million - Investing.com
Biomaterials company Nexgel announces a key partnership with new strategic partner Sequence Lifescience™ - Bitget
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment - The Manila Times
Celularity (NASDAQ: CELU) closes NexGel asset sale as Helena note default looms - Stock Titan
Celularity Closes Transaction with NexGel to Monetize Biomaterials - Intellectia AI
Celularity sells biomaterials assets, cuts nearly $13M of debt - Stock Titan
NexGel Inc stock (US65340W1027): Is its hydrogel tech edge strong enough for medtech growth? - AD HOC NEWS
NEXGEL, Inc. completed the acquisition of Portfolio of Commercial-stage Regenerative Biomaterial Products of Celularity Inc. for 15.8 million. - marketscreener.com
NEXGEL reschedules shareholder call, revises financing plan - MSN
NexGel Inc stock (US65340W1027): Why its hydrogel tech edge matter more now for specialized medical - AD HOC NEWS
NEXGEL (NXGL) price target decreased by 66.67% to 2.04 - MSN
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET - The Manila Times
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):